Generic Medicines.

Slides:



Advertisements
Similar presentations
6th European Patients’ Rights Day The EMA Geriatric Medicines Strategy and the empowered aging patient Francesca Cerreta EMA (European Medicines Agency)
Advertisements

NPS is an independent, non-profit organisation for Quality Use of Medicines, funded by the Australian Government Department of Health and Ageing. Safe.
What is a Generic Medication?. The World Health Organization Definition of a Generic Medication A generic drug is a pharmaceutical product, usually intended.
Prescribing in Practice Part 2e Licensing, Legal Categories and Group Activity.
Christine Simmon Senior Vice President, Policy & Strategic Alliances Generic Pharmaceutical Association November 6, 2014 Biologics Naming.
AND GENERIC DRUGS BRAND-NAME AND GENERIC DRUGS WHAT TO CHOOSE? Natalia VEZIKOVA, MD, PhD, Natalia VEZIKOVA, MD, PhD, MSc The Head of the Hospital Therapy.
Pharmacology II. The Business of Sick.
Unlicensed Medicines in Paediatrics Is there a problem ? Scottish Neonatal and Paediatric Pharmacist Group National Paediatric Pre- Registration Pharmacist.
The basics about over-the-counter and prescription drugs. 1 Medicine 101.
What You Want to Know About Generic Drugs Generic Drugs: Safe. Effective. FDA-Approved.
Data protection and extension of patent rights TRIPS requirements & TRIPS-plus provisions Carlos Correa.
PATENTSHIP. What is a Patent?  Patent  is an exclusive and monopoly right  to use the patented invention  for a limited area and time (20 Years) 
Understanding Medicines Ch. 23 pp Lesson 1: The Role of Medicines Classification of Medicines A.Prevent disease B.Fight pathogens C.Relieve.
Authorisation of medicinal products: selected challenges Rocío Salvador Roldán Pharmaceuticals Unit/DG SANCO This presentation only reflects the views.
ACCESS TO MEDICINES - POLICY AND ISSUES
Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.
Marcel H.N. Hoefnagel 2 November 2007 BIOSIMILARS are not Generics But similar.
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
Top 9 benefits of generic pharmacy Published by :
Date Insert on Master Slide Slide 1 Regulatory Framework within which patients can have safe and more convenient access to medicines Royal College of Physicians.
The process of drug development. Drug development 0,8 – 1 mld. USD.
REGULATION (EC) Nº 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products 1 Shall apply from 11.
Clinical Trials.
BY : Dr.Roshini Murugupillai. Pharmacology (Greek : pharmacon – drug ; logos – discourse in) It is the science of drugs It deals with interaction of exogenously.
Difference to Generics What can they do for us in the future
Off-label Use.
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
Paediatric Medicine: The Paediatric Investigation Plan
Quality of the medicinal products. Drug switching.
Switching to Generic Antiepileptic Drugs (AEDs)
Making the Connection ISO Master Class An Overview.
Efficacy and Safety of Medicines
Basic Facts in pharmacy
Information on Medicinal Products
BASICS IN PHARMA.
Tracking information becomes available soon after the order has been dispatched and is updated throughout the whole delivery period. We are committed to.
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
Risk Communication in Medicines
DIA Clinical Safety and Pharmacovigilance Community
The Many Careers of Pharmacy
Herbal Medicines.
Medicines Optimisation
Medications.
PHARMACEUTICAL QUALITY
Using Medicines Safely (2:50)
What’s Your Health IQ? True or False
Over the Counter (OTC) Drugs & Dietary Supplements Market Global Opportunity Analysis and Industry Forecast,
Pharmacist- Career Opportunities
Introduction to Biosimilars
CHAWLA MEDICOS Present’s Branded v/s Generic medicine
Bell Ringer Open your student workbook to page 51.
AIKTC - School of Pharmacy
Health Technology Assessment
Drug and Drug Products Quality & Testing
Questions you may get from your EU customers, and
Biosimilars to recombinant human FSH medicines: comparable efficacy and safety to the original biologic  Fernando de Mora, Bart C.J.M. Fauser  Reproductive.
Using Medicines Safely (2:50)
Towards International Harmonized Nomenclature for Medical Devices
Ch 18: Pharmacy.
No Deal EU Businesses Workshop: New Approach goods and the UK marking
Compounded Drugs and Lack of Premarket FDA-Approval
Prescription vs. OTC.
Introduction to Basic Research Methods
Pharmaceuticals Industry
Generic vs Name Brand Drugs
The British Retail Consortium (BRC)
Radiopharmaceutical Production
Process mapping of registration to reimbursement for new pharmaceuticals in UK Description: A systematic methodology was developed in order to create the.
Presentation transcript:

Generic Medicines

Generics When chemical medicines are first developed and approved, they are sold by a pharmaceutical company under a brand name. Once the protection of the product expires for example, patents or regulatory protection such as data exclusivity, the company no longer has exclusive rights to sell the medicine. Other companies can then apply to manufacture and sell a comparable medicine with the same active pharmaceutical ingredient (API). This new version is often referred to as a ’generic’.

What is a Generic Medicine? A generic medicinal product is defined as a medicinal product that has: the same composition - qualitative and quantitative, in active substance(s) as the original, the reference medicinal product (typically brand-name products), the same pharmaceutical form – e.g. tablet, syrup, inhaler, etc. as the reference medicinal product and has been shown to interact with the body in a similar manner to the reference medicinal product.

What is a Generic Medicine? Chemically, there is no difference between the original branded medicine and the generic medicine. As with all medicines, generics must comply with appropriate regulatory approval processes assessing and ensuring quality, safety, and efficacy. Approved generics are regulated in the same way that original medicines are regulated.

Generic Names The original medicine and the generic medicine will have different brand names, appearances, and packaging but contain the same active ingredients. Essentially, they can be considered the same medicine. This could cause confusion were it not for the generic name (International Nonproprietary Name, INN) which is shared by all brands of the medicine. Examples of such names are well known for pain medications – for instance, active ingredients such as paracetamol and ibuprofen are used as the basis for many of the painkillers that can be bought in pharmacies.

Cost and Quality of Generic Medicines The key benefit of generics and the reason that they are preferred by many patients, doctors, and hospitals is that they often cost much less than original medicines. Because of their comparatively low cost, the equality of generics and original medicines is often questioned by patients. Generic medicines cost less than the original medicine because the costs of research and development have been covered by the company that marketed the original medicine. However, generic medicines are manufactured according to the same quality standards as all other medicines.

Regulation of Generics Generic medicines are regulated in the same way as the original medicines. The generic company does not need to demonstrate non- clinical or clinical test results for their products before obtaining a marketing authorisation. The generic medicine is tested to show that it produces the same levels of the active substance in the body as the original medicine before obtaining a marketing authorisation. Manufacturing facilities and conditions must be of a very high standard. Following approval of a generic medicine, the company producing it must commit to the collection and reporting of additional post-marketing safety data.

Reported problems There have been problems reported by patients who changed from the original medicine to its generic form, and vice versa. These problems appear to come from variation in the inactive ingredients, for example, a patient may have an allergy to an inactive ingredient used in a generic formulation.